DRIO
HEALTHCAREDarioHealth Corp
$7.98-0.01 (-0.13%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving DRIO Today?
No stock-specific AI insight has been generated for DRIO yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$5.93$17.74
$7.98
Fundamentals
Market Cap$59M
P/E Ratio—
EPS$-10.12
Dividend Yield—
Dividend / Share—
ROE-0.6%
Profit Margin-1.9%
Debt / Equity—
Trading
Volume4K
Avg Volume (10D)—
Shares Outstanding7.3M
DRIO News
20 articles- Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue EstimatesYahoo Finance·May 7, 2026
- DarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026Yahoo Finance·May 4, 2026
- Pulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 4, 2026
- Dario Demonstrates Improved Workplace Function and Productivity Outcomes Through Digital Behavioral Health Program: Real-World Study Published in JMIR Formative ResearchYahoo Finance·Apr 20, 2026
- Dario Appoints Veteran Healthcare Executive John R. Palumbo to Board of Directors to Support Accelerated Commercial ScalingYahoo Finance·Apr 13, 2026
- How The DarioHealth (DRIO) Story Is Shifting With New Targets Research And GLP 1 FocusYahoo Finance·Mar 24, 2026
- DarioHealth Corp (DRIO) Q4 2025 Earnings Call Highlights: Strategic Growth Amid Revenue ChallengesYahoo Finance·Mar 19, 2026
- DarioHealth Corp. Q4 2025 Earnings Call SummaryMoby·Mar 19, 2026
- DarioHealth (DRIO) Q4 2025 Earnings TranscriptMotley Fool·Mar 19, 2026
- DarioHealth Q4 Earnings Call HighlightsMarketbeat·Mar 19, 2026
- DarioHealth Corp. (DRIO) Reports Q4 Loss, Beats Revenue EstimatesYahoo Finance·Mar 19, 2026
- DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating ResultsYahoo Finance·Mar 19, 2026
- DarioHealth Corp (DRIO) Q4 2025 Earnings Report Preview: What To ExpectYahoo Finance·Mar 18, 2026
- DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026Yahoo Finance·Mar 11, 2026
- Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital HealthYahoo Finance·Mar 10, 2026
- Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight ManagementYahoo Finance·Mar 3, 2026
- OPKO Health (OPK) Reports Q4 Loss, Tops Revenue EstimatesYahoo Finance·Feb 26, 2026
- Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based PlatformsYahoo Finance·Jan 21, 2026
- How The DarioHealth (DRIO) Story Is Shifting With A Higher Target And Ongoing RisksYahoo Finance·Jan 9, 2026
- Why The Narrative Around DarioHealth Is Shifting After New Results And Valuation UpdatesYahoo Finance·Dec 15, 2025
All 20 articles loaded
Price Data
Open$7.90
Previous Close$7.99
Day High$8.05
Day Low$7.68
52 Week High$17.74
52 Week Low$5.93
52-Week Range
$5.93$17.74
$7.98
Fundamentals
Market Cap$59M
P/E Ratio—
EPS$-10.12
Dividend Yield—
Dividend / Share—
ROE-0.6%
Profit Margin-1.9%
Debt / Equity—
Trading
Volume4K
Avg Volume (10D)—
Shares Outstanding7.3M
About DarioHealth Corp
DarioHealth Corp. The company is headquartered in New York, New York.
HEALTHCAREHEALTH INFORMATION SERVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICHEALTH INFORMATION SERVICES
CIK—
Composite FIGI—
Share Class FIGI—